A Single-center, Randomized, Open-label, Active-controlled Phase Ic/IIb Study to Evaluate the Efficacy Safety and Pharmacokinetics of Hepenofovir Fumarate Tablets in Patients With CHB
Latest Information Update: 10 Nov 2023
At a glance
- Drugs Hepenofovir fumarate (Primary) ; Tenofovir alafenamide
- Indications Hepatitis B
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Xian Xintong Pharmaceutical Research
Most Recent Events
- 10 Nov 2023 New trial record